Abstract
In this chapter we discuss how to respond to and address requests by a patient for a hastened death. The initial response should always be exploration and maximization of palliative care. For persistent requests to hasten death that are rational and not the result of inadequate palliative care, discussion and education about the following options are appropriate: withdrawal/withholding of life-sustaining treatment, palliative sedation, voluntarily stopping eating and drinking (VSED), physician-assisted death (PAD), and voluntary active euthanasia (VAE). This discussion will be colored by the legal status for the latter two options in the jurisdiction in which the conversation is being held. We recommend referral to a palliative medicine specialist if there is any uncertainty about the appropriateness of the intervention, and in all cases where palliative sedation to unconsciousness, VSED, PAD, or VAE are being considered. Neurologic patients may present particular challenges in these circumstances. We use amyotrophic lateral sclerosis (ALS), Parkinson disease, Alzheimer’s disease, Huntington’s disease, stroke, and glioblastoma as model diseases to explore the special circumstances in neurology and how various options for a hastened death may be more or less appropriate depending on the underlying illness.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Carver AC, et al. End-of-life care: a survey of US neurologists’ attitudes, behavior, and knowledge. Neurology. 1999;53(2):284–93.
Quill TE, Battin MP. Physician-assisted dying: the case for palliative care and patient choice. Baltimore: Johns Hopkins University Press; 2004. xv, 342 p
Quill T, Arnold RM. Evaluating requests for hastened death #156. J Palliat Med. 2008;11(8):1151–2.
Ganzini L, Goy ER, Dobscha SK. Why Oregon patients request assisted death: family members’ views. J Gen Intern Med. 2008;23(2):154–7.
Meier DE, et al. Characteristics of patients requesting and receiving physician-assisted death. Arch Intern Med. 2003;163(13):1537–42.
Tolle SW, et al. Characteristics and proportion of dying Oregonians who personally consider physician-assisted suicide. J Clin Ethics. 2004;15(2):111–8.
Wang LH, et al. Death with dignity in Washington patients with amyotrophic lateral sclerosis. Neurology. 2016;87(20):2117–22.
Battin MP, et al. Physician-assisted suicide: toward a comprehensive understanding. Report of the Task Force on Physician-assisted Suicide of the Society for Health and Human Values. Acad Med. 1995;70(7):583–90.
Foley KM, Hendin H. The case against assisted suicide: for the right to end-of-life care. Baltimore: Johns Hopkins University Press; 2002. xii, 371 p
Battin MP, et al. Legal physician-assisted dying in Oregon and the Netherlands: evidence concerning the impact on patients in “vulnerable” groups. J Med Ethics. 2007;33(10):591–7.
Emanuel EJ, et al. Attitudes and practices of euthanasia and physician-assisted suicide in the United States, Canada, and Europe. JAMA. 2016;316(1):79–90.
Quill TE, Kimsma G. End-of-life care in The Netherlands and the United States: a comparison of values, justifications, and practices. Camb Q Healthc Ethics. 1997;6(2):189–204.
Burkle CM, Schipper AM, Wijdicks EF. Brain death and the courts. Neurology. 2011;76(9):837–41.
Wijdicks EF, et al. Evidence-based guideline update: determining brain death in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2010;74(23):1911–8.
Quill TE, Abernethy AP. Generalist plus specialist palliative care – creating a more sustainable model. N Engl J Med. 2013;368(13):1173–5.
Holloway R. Patients who never leave us. Neurology. 2011;77(15):3.
Russell JA, Williams MA, Drogan O. Sedation for the imminently dying: survey results from the AAN Ethics Section. Neurology. 2010;74(16):1303–9.
ten Have H, Welie JV. Palliative sedation versus euthanasia: an ethical assessment. J Pain Symptom Manag. 2014;47(1):123–36.
Pope TM, West A. Legal briefing: voluntarily stopping eating and drinking. J Clin Ethics. 2014;25(1):68–80.
Quill TE, Lo B, Brock DW. Palliative options of last resort: a comparison of voluntarily stopping eating and drinking, terminal sedation, physician-assisted suicide, and voluntary active euthanasia. JAMA. 1997;278(23):2099–104.
Ivanovic N, Buche D, Fringer A. Voluntary stopping of eating and drinking at the end of life – a ‘systematic search and review’ giving insight into an option of hastening death in capacitated adults at the end of life. BMC Palliat Care. 2014;13(1):1.
Bolt EE, et al. Primary care patients hastening death by voluntarily stopping eating and drinking. Ann Fam Med. 2015;13(5):421–8.
Meier DE, et al. A national survey of physician-assisted suicide and euthanasia in the United States. N Engl J Med. 1998;338(17):1193–201.
Initiative and Referendum Institute. 2017. Cited 8 Feb 2017. Available from: http://www.iandrinstitute.org/index.cfm.
Okie S. Physician-assisted suicide – Oregon and beyond. N Engl J Med. 2005;352(16):1627–30.
Hedberg K, Hopkins D, Kohn M. Five years of legal physician-assisted suicide in Oregon. N Engl J Med. 2003;348(10):961–4.
Brody H. Kevorkian and assisted death in the United States. BMJ. 1999;318(7189):953–4.
van der Heide A, et al. End-of-life decision-making in six European countries: descriptive study. Lancet. 2003;362(9381):345–50.
van der Heide A, et al. End-of-life practices in the Netherlands under the Euthanasia Act. N Engl J Med. 2007;356(19):1957–65.
Rabkin J, et al. Cognitive impairment, behavioral impairment, depression, and wish to die in an ALS cohort. Neurology. 2016;87(13):1320–28.
Ganzini L, et al. Attitudes of patients with amyotrophic lateral sclerosis and their care givers toward assisted suicide. N Engl J Med. 1998;339(14):967–73.
Veldink JH, et al. Euthanasia and physician-assisted suicide among patients with amyotrophic lateral sclerosis in the Netherlands. N Engl J Med. 2002;346(21):1638–44.
Brookmeyer R, et al. Survival following a diagnosis of Alzheimer disease. Arch Neurol. 2002;59(11):1764–7.
Roberson ED, et al. Frontotemporal dementia progresses to death faster than Alzheimer disease. Neurology. 2005;65(5):719–25.
de Beaufort ID, van de Vathorst S. Dementia and assisted suicide and euthanasia. J Neurol. 2016;263(7):1463–7.
Henig R.M. The last day of her life. The New York Times Magazine 2015 May 14 2015. Cited 16 October 2016. Available from: http://www.nytimes.com/2015/05/17/magazine/the-last-day-of-her-life.html.
Goodarzi Z, et al. Detecting depression in Parkinson disease: a systematic review and meta-analysis. Neurology. 2016;87(4):426–37.
Buter TC, et al. Dementia and survival in Parkinson disease: a 12-year population study. Neurology. 2008;70(13):1017–22.
Aarsland D, et al. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol. 2003;60(3):387–92.
Peralta E. As planned, right-to-die advocate brittany maynard ends her life. The Two-Way November 3, 2014. Available from: http://www.npr.org/sections/thetwo-way/2014/11/03/361094919/as-planned-right-to-die-advocate-brittany-maynard-ends-her-life.
Omuro A, DeAngelis LM. Glioblastoma and other malignant gliomas: a clinical review. JAMA. 2013;310(17):1842–50.
Woehrer A, Bauchet L, Barnholtz-Sloan JS. Glioblastoma survival: has it improved? Evidence from population-based studies. Curr Opin Neurol. 2014;27(6):666–74.
Quill TE, Holloway R. Time-limited trials near the end of life. JAMA. 2011;306(13):1483–4.
Paulsen JS, et al. Depression and stages of Huntington’s disease. J Neuropsychiatry Clin Neurosci. 2005;17(4):496–502.
Di Maio L, et al. Onset symptoms in 510 patients with Huntington’s disease. J Med Genet. 1993;30(4):289–92.
Duff K, et al. Psychiatric symptoms in Huntington’s disease before diagnosis: the predict-HD study. Biol Psychiatry. 2007;62(12):1341–6.
Kirkwood SC, et al. Progression of symptoms in the early and middle stages of Huntington disease. Arch Neurol. 2001;58(2):273–8.
Koennecke HC, et al. Factors influencing in-hospital mortality and morbidity in patients treated on a stroke unit. Neurology. 2011;77(10):965–72.
Andersen KK, Andersen ZJ, Olsen TS. Predictors of early and late case-fatality in a nationwide Danish study of 26,818 patients with first-ever ischemic stroke. Stroke. 2011;42(10):2806–12.
Saver JL, Altman H. Relationship between neurologic deficit severity and final functional outcome shifts and strengthens during first hours after onset. Stroke. 2012;43(6):1537–41.
Quill TE. Doctor, I want to die. Will you help me? JAMA. 1993;270(7):870–3.
Dobscha SK, et al. Oregon physicians’ responses to requests for assisted suicide: a qualitative study. J Palliat Med. 2004;7(3):451–61.
Emanuel EJ, et al. The practice of euthanasia and physician-assisted suicide in the United States: adherence to proposed safeguards and effects on physicians. JAMA. 1998;280(6):507–13.
Shanafelt TD, et al. Burnout and satisfaction with work-life balance among US physicians relative to the general US population. Arch Intern Med. 2012;172(18):1377–85.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Weisbrod, N., Quill, T.E. (2019). Addressing and Managing Requests to Hasten Death. In: Creutzfeldt, C., Kluger, B., Holloway, R. (eds) Neuropalliative Care. Springer, Cham. https://doi.org/10.1007/978-3-319-93215-6_14
Download citation
DOI: https://doi.org/10.1007/978-3-319-93215-6_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-93214-9
Online ISBN: 978-3-319-93215-6
eBook Packages: MedicineMedicine (R0)